Antibiotice SA 2018 Annual Report with Sustainability Disclosures
The report outlines the performance and strategic initiatives of Antibiotice SA for the financial year 2018. The company achieved an 8% increase in sales revenue and a 2% increase in net profit compared to 2017, driven by international sales growth, particularly in Vietnam and North America. Key developments included the construction of a new Ointment and Suppository Plant and the implementation of an Intelligent Energy Monitoring System. Additionally, the company advanced its corporate social responsibility efforts through programs focused on health, education, and environmental protection, such as the 'Antibiotics of the 3rd Millennium' initiative.
Company: Antibiotice SA
Sector: Manufacturing
Country: Romania
Year: 2018
Type: Annual Report with Sustainability Disclosures
Pages: 48
Back to company
Antibiotice SA
Management Report
The report outlines the performance and strategic initiatives of Antibiotice SA for the financial year 2018. The company achieved an 8% increase in sales revenue and a 2% increase in net profit compared to 2017, driven by international sales growth, particularly in Vietnam and North America. Key developments included the construction of a new Ointment and Suppository Plant and the implementation of an Intelligent Energy Monitoring System. Additionally, the company advanced its corporate social responsibility efforts through programs focused on health, education, and environmental protection, such as the 'Antibiotics of the 3rd Millennium' initiative.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Published
Mar 13, 2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees